Search results for Mylan Laboratories, Inc.

Showing of 1 - 10 from 17 results

India risks missing boat as biosimilars shake up drug industry | Reuters

Oct 14, 2015

India risks missing boat as biosimilars shake up drug industry | Reuters

that have stated plans to make biosimilars for the United States and Europe are all partnered with larger Western firms. Biocon has a tie-up with Mylan Inc (MYL.O) and is testing fo
Teva to buy Allergan generic business for $40.5 billion, drops <b>Mylan</b> bid| Reuters

Jul 28, 2015

Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid| Reuters

scale, crucial in the low-margin generic drugs business. Teva (TEVA.TA) (TEVA.N), which dropped its hostile pursuit of Mylan (MYL.O), will likely have to sell off some drugs to allay antitrust
Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the g
India may take WTO action against EU over drug clinical trials - GVK  | Reuters

Apr 15, 2015

India may take WTO action against EU over drug clinical trials - GVK | Reuters

suspended by the EMA include those made by U.S. firms Mylan Inc (MYL.O) and Abbott Laboratories (ABT.N), as well as large Indian companies such as Lupin Ltd (LUPN.NS) and Dr Redd
Wall St falls from latest records; auto sales soft

Mar 03, 2015

Wall St falls from latest records; auto sales soft

Holdings Inc to subprime lender Springleaf Holdings Inc for $4.25 billion in cash. Springleaf shares surged 36.5 percent to $48.13.Mylan Inc fell 3.3 percent to $55.98. Th
FIPB clears 11 FDI proposals, refers Glenmark, Aurobindo deals to CCEA

Feb 20, 2015

FIPB clears 11 FDI proposals, refers Glenmark, Aurobindo deals to CCEA

the investment involved in each of the proposal is above Rs 1,200 crore," the statement said.Besides, FIPB has deferred an investment proposal of Hyderabad- based Mylan Laboratorie
U.S. companies may not be fleeing due to high tax rate, Reuters analysis shows

Feb 10, 2015

U.S. companies may not be fleeing due to high tax rate, Reuters analysis shows

(STE.N), Mylan Inc (MYL.O), C&J Energy Services Inc (CJES.N) and Burger King, which has been renamed Restaurant Brands International Inc (QSR.TO).All six have rece
All-stock deal: India's Strides Arcolab to buy Shasun Pharma for $200 mn

Sep 29, 2014

All-stock deal: India's Strides Arcolab to buy Shasun Pharma for $200 mn

consolidation in the pharmaceutical sector, which was expected to happen after Sun Pharmaceutical Industries Ltd agreed in April to buy local rival Ranbaxy Laboratories Ltd for $3.2 billion to
FIPB clears GSK's Rs 6,400 cr FDI proposal to hike stake in India

Jan 13, 2014

FIPB clears GSK's Rs 6,400 cr FDI proposal to hike stake in India

,168-crore deal of the US-based Mylan Inc for acquiring Bangalore-based pharma firm Agila Specialties, a subsidiary of Strides Arcolab.In 2008, Japanese firm Daiichi Sankyo had bought ou
Govt continues to allow 100% FDI in existing pharma firms

Jan 08, 2014

Govt continues to allow 100% FDI in existing pharma firms

meeting dismissed the DIPP concerns.In September, the government cleared the Rs 5,168-crore deal of the US-based Mylan Inc for acquiring Bangalore-based pharma firm Agila Specialties, a